You nominated and our expert judging panels deliberated – and now, we proudly showcase this diversity of talent in The Pathologist’s 2020 Power List.
Anthony Whetton, Director of the Stoller Biomarker Discovery Centre, Manchester, UK
Michael Laposata, co-author of the IoM report, speaks out…
We can argue about how many diagnostic errors happen each year, but we can’t deny that there are too many of them. And when one of those errors is ours, denial is especially inappropriate – but how many of us feel comfortable about a confessional with the patient? In the first installment of a two-part feature, we examine the difficulties around disclosure and communication of diagnostic errors.
FDA issues first-ever approval for liquid biopsy companion diagnostic
What labs need to know about the importance of ISO 15189 accreditation.
New regulations in the US set to change the way LDTs are developed – and could stifle innovation
What is "The Individual Quality Control Plan (IQCP)" and should test sites adopt it?
The secretive diagnostic startup has been making headlines – but not always for the right reasons…
Why we need to harmonize fasting definitions for blood sampling
The accuracy and impact of POC glucose testing is raising concerns - what are the alternatives?
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.